RCMI Coordinating Center (RCMI CC) Header Logo

Connection

David A. Foster to Prostatic Neoplasms

Back to Details
This is a "connection" page, showing publications David A. Foster has written about Prostatic Neoplasms.
David A. Foster
Connection Strength
0.745
Prostatic Neoplasms
  1. Chakraborty S, Utter MB, Frias MA, Foster DA. Cancer cells with defective RB and CDKN2A are resistant to the apoptotic effects of rapamycin. Cancer Lett. 2021 12 01; 522:164-170.
    View in: PubMed
    Score: 0.418
  2. Utter M, Chakraborty S, Goren L, Feuser L, Zhu YS, Foster DA. Elevated phospholipase D activity in androgen-insensitive prostate cancer cells promotes both survival and metastatic phenotypes. Cancer Lett. 2018 06 01; 423:28-35.
    View in: PubMed
    Score: 0.327
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support